Approvals & Mergers: Inside Enzyvant with Bill Symonds, Pharm.D.
Business Of Biotech
00:00
The Ease of Procurement and Supply Chain Issues
There's probably 100 plus, you know, items which are used in the manufacturer of a single batch. So there's a lot of very very specific things that have to be done in designing it so they like this. But I think overall we've seen a general easing of that and things are opening up more and more. We were made on track with our initial timelines for debt facility. That's the ultimate test where we're able to keep the facility on track.
Transcript
Play full episode
